Clinical Trials Browser

INDUSTRY × Has results × Everolimus × Clear all

Carcinoma, Renal Cell

Breast Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Carcinoma, Renal Cell

Pancreatic Neuroendocrine Tumors

Breast Neoplasms

Breast Neoplasms

Carcinoma, Renal Cell

Adenoma, Islet Cell

Glioma, Recurrence, Rhabdomyosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

Breast Neoplasms

Neoplasm Metastasis

Carcinoma, Renal Cell

Carcinoma, Renal Cell, Neoplasm Metastasis

Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

Neuroendocrine Tumors

Digestive System Neoplasms, Sarcoma, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Carcinoid Tumor, Neoplasms, Neuroendocrine Tumors

Lymphoma, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

Carcinoma, Renal Cell

Carcinoma, Neuroendocrine

Breast Neoplasms

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

Breast Neoplasms, Neoplasm Metastasis

Lymphangioleiomyomatosis

Breast Neoplasms

Breast Diseases, Breast Neoplasms, Neoplasms, Skin Diseases

Carcinoma, Renal Cell

Colorectal Neoplasms

Carcinoma, Carcinoma, Renal Cell

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasm Metastasis, Neuroendocrine Tumors

Carcinoid Tumor, Carcinoma, Neuroendocrine Tumors

Breast Neoplasms, Neoplasm Metastasis

Neuroendocrine Tumors

Tuberous Sclerosis Complex-associated Refractory Seizures

Carcinoma, Renal Cell, Kidney Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms

Breast Neoplasms

Margins of Excision, Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell

Advanced Breast Cancer

Adenoma, Islet Cell, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

Carcinoma, Renal Cell, Kidney Neoplasms

Carcinoma, Carcinoma, Hepatocellular

Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell

Clinical Trials

CLEAR

AMEERA-1

BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer

A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

BOLERO-5

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

OPALINE

Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

BOLERO-4

A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease

ENTRATA

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

RADIANT-4

Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

PILLAR-1

METEOR

LUNA

Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

BOLERO-6

A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.

EVEREXES

4EVERUK

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

A Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment

GSK1120212 Rollover Study

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

RAMSETE/CDE16

BOLERO-1

An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)

EXIST-3

Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)

Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

TRACER

BOLERO-2

BOLERO-3

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer

COOPERATE-2

RECORD-3

EVOLVE-1

MACS0460